Commentary on “transcription regulation by long non-coding RNAs: mechanisms and disease relevance”
Abstract
The review article “Transcription regulation by long non-coding RNAs: mechanisms and disease relevance” by Jorge Ferrer and Nadya Dimitrova, published in Nature Reviews Molecular Cell Biology, explores the complex roles of long non-coding RNAs (lncRNAs) in gene transcription regulation. The authors discuss various mechanisms by which lncRNAs influence transcription, including their functions as cis-regulatory elements, transcription stabilizers, and scaffolds for regulatory complexes. The review also highlights the potential of lncRNAs in disease contexts and their therapeutic applications. However, it is essential to consider the potential limitations in current lncRNA research.
Keywords
Mechanistic insights of lncRNA functions
The review article by Ferrer and Dimitrova[1], published in Nature Reviews Molecular Cell Biology, provides a comprehensive overview of the emerging roles of lncRNAs in transcription regulation. It covers a wide range of lncRNA functions, from local cis-acting roles to broader trans-regulatory effects, providing a detailed understanding of their regulatory potential. By addressing various mechanisms and providing specific examples, the review successfully illustrates the complexity and versatility of lncRNAs in gene regulation such as transcription activation, stabilization, and allele-specific repression. For example, the authors describe how lncRNAs like XIST control X-chromosome inactivation, providing a clear example of how lncRNAs can regulate gene expression on a chromosomal scale, while others, like imprinted lncRNAs, direct allele-specific repression[2,3]. The authors also describe how lncRNAs like lincRNA-p21 and Maenli contribute to local activation of gene transcription through distinct mechanisms[4,5].
The discussion on specific mechanisms such as scaffold functions and transcriptional condensates elucidates the formation of RNA-protein complexes and the role of lncRNAs in chromatin organization. For instance, they discuss how lncRNA HOTTIP serves as scaffolds for regulatory complexes (MLL1 and WDR5), bringing chromatin-modifying enzymes into proximity with their target gene (HOXA)[6]. These details help elucidate how lncRNAs exert their regulatory effects, making complex concepts accessible to readers. By citing experimental studies that elucidate the roles of lncRNAs, such as defects in the transcription-stabilizing lncRNA CHASERR leading to developmental defects[7], readers can delve deeper into specific studies to explore the topic further.
LncRNAs in human diseases
The section on the involvement of lncRNAs in human diseases and their therapeutic potential is highly relevant and timely, considering the crucial regulatory roles of lncRNAs in various biological processes and in human diseases. The growing interest in lncRNAs in biomedical research is fueled by advancements in detection methods, which have led to the identification of a significantly higher number of lncRNAs - now exceeding the total number of protein-coding genes[8]. These improvements in sensitivity and specificity have expanded our understanding of lncRNA functions and their distribution across different cellular compartments, including the nucleus, nucleolus, cytoplasm, and mitochondria[9]. LncRNAs are primarily transcribed by RNA polymerase II, similar to protein-coding genes, and often undergo post-transcriptional modifications that further modulate their functions[10]. The localization of lncRNAs in various cellular compartments suggests that they may play diverse roles in gene regulation, chromatin organization, and cellular signaling, impacting a wide range of physiological and pathological processes[10].
A growing body of evidence suggests a mechanistic link between lncRNA dysregulation and the onset and progression of numerous human diseases, including cancer, cardiovascular disorders, and neurological conditions. For instance, in cancer, lncRNAs like PVT1 have been implicated in tumorigenesis by stabilizing oncogenic mRNAs such as MYC, thereby promoting tumor growth and progression[11]. Elevated levels of ANRIL, HOTAIR, LINC00641, LINC00565, MALAT1, and SAMMSON, along with decreased GAS5, have been identified as blood biomarkers that could enhance early detection and improve outcomes in glioblastoma multiforme, an aggressive and fatal brain tumor[12]. Similarly, the lncRNA Hdnr has been associated with cardiac malformations through its influence on Hand2 expression[13]. These examples underscore the translational potential of lncRNA research, particularly in identifying novel therapeutic targets and developing new diagnostic biomarkers. The dysregulation of lncRNAs in various diseases positions them as promising candidates for therapeutic intervention. Targeting specific lncRNAs could offer a novel approach to treating diseases where traditional therapies have been ineffective. Additionally, the ability of lncRNAs to serve as biomarkers may enhance the early detection and diagnosis of diseases, ultimately improving patient outcomes.
Limitations in current lncRNA research
Although advanced methodologies, such as single-cell RNA sequencing, have revealed the complexity and heterogeneity of lncRNA expression[14], low expression levels of lncRNAs make them difficult to detect and quantify accurately. Current RNA sequencing technologies might miss these low-abundance transcripts. While single-cell RNA sequencing offers high resolution, it often suffers from dropouts where some transcripts are not detected in every cell, leading to incomplete representation of lncRNA expression profiles.
Advanced CRISPR methods, including CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa), have facilitated the identification of numerous lncRNAs with critical regulatory functions[15]. However, the limitations of CRISPR in identifying critical regulatory functions of lncRNAs include off-target effects, incomplete knockouts, targeting difficulties in repetitive regions, complexity of lncRNA functions, compensatory cellular mechanisms, and the inability to capture interactions with proteins, other RNAs, or chromatin modifications.
In addition, a significant proportion of identified lncRNAs lack functional annotation. Many lncRNAs are classified based on expression data alone without experimental validation, leading to uncertainty about their biological roles. Furthermore, functional redundancy among lncRNAs supports the robustness of gene regulatory networks, maintaining stable gene expression even when certain lncRNAs are deleted or mutated[16]. Moreover, investigating the evolutionary origins and conservation of lncRNAs across species provides valuable insights into their functional significance.
However, the review article by Ferrer and Dimitrova[1] does not address these current limitations in lncRNA research, highlighting the importance of considering these challenges as the field continues to advance.
Conclusion
The review by Ferrer and Dimitrova provides an excellent foundation for understanding the diverse roles of lncRNAs in transcription regulation. The article effectively highlights the significance of lncRNAs; however, the readers should be aware of potential limitations in current lncRNA research. Future research should continue to explore the multifaceted roles of lncRNAs, leveraging advanced technologies and considering evolutionary and functional redundancy aspects to fully elucidate their contributions to gene regulation and disease.
DECLARATIONS
Authors’ contributions
The author contributed solely to the article.
Availability of data and materials
Not applicable.
Financial support and sponsorship
This work was supported in part by the funding from the American Heart Association Grant #940594/Narasimman Gurusamy/2022.
Conflicts of interest
The author declared that there are no conflicts of interest.
Ethical approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Copyright
© The Author(s) 2024.
REFERENCES
1. Ferrer J, Dimitrova N. Transcription regulation by long non-coding RNAs: mechanisms and disease relevance. Nat Rev Mol Cell Biol 2024;25:396-415.
2. Jacobson EC, Pandya-Jones A, Plath K. A lifelong duty: how xist maintains the inactive X chromosome. Curr Opin Genet Dev 2022;75:101927.
3. Rosspopoff O, Cazottes E, Huret C, et al. Species-specific regulation of XIST by the JPX/FTX orthologs. Nucleic Acids Res 2023;51:2177-94.
4. Winkler L, Jimenez M, Zimmer JT, Williams A, Simon MD, Dimitrova N. Functional elements of the cis-regulatory lincRNA-p21. Cell Rep 2022;39:110687.
5. Allou L, Balzano S, Magg A, et al. Non-coding deletions identify Maenli lncRNA as a limb-specific En1 regulator. Nature 2021;592:93-8.
6. Pradeepa MM, McKenna F, Taylor GCA, et al. Psip1/p52 regulates posterior Hoxa genes through activation of lncRNA hottip. PLoS Genet 2017;13:e1006677.
7. Rom A, Melamed L, Gil N, et al. Regulation of CHD2 expression by the Chaserr long noncoding RNA gene is essential for viability. Nat Commun 2019;10:5092.
8. Tsagakis I, Douka K, Birds I, Aspden JL. Long non-coding RNAs in development and disease: conservation to mechanisms. J Pathol 2020;250:480-95.
9. Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol 2021;220:e202009045.
10. Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 2021;22:96-118.
12. Pokorná M, Černá M, Boussios S, Ovsepian SV, O’Leary VB. lncRNA biomarkers of glioblastoma multiforme. Biomedicines 2024;12:932.
13. Ritter N, Ali T, Kopitchinski N, et al. The lncRNA locus handsdown regulates cardiac gene programs and is essential for early mouse development. Dev Cell 2019;50:644-57.e8.
14. Pinkney HR, Black MA, Diermeier SD. Single-cell RNA-seq reveals heterogeneous lncRNA expression in xenografted triple-negative breast cancer cells. Biology 2021;10:987.
15. Kampmann M. CRISPRi and CRISPRa screens in mammalian cells for precision biology and medicine. ACS Chem Biol 2018;13:406-16.
Cite This Article
Export citation file: BibTeX | EndNote | RIS
OAE Style
Gurusamy N. Commentary on “transcription regulation by long non-coding RNAs: mechanisms and disease relevance”. J Transl Genet Genom 2024;8:281-4. http://dx.doi.org/10.20517/jtgg.2024.24
AMA Style
Gurusamy N. Commentary on “transcription regulation by long non-coding RNAs: mechanisms and disease relevance”. Journal of Translational Genetics and Genomics. 2024; 8(3):281-4. http://dx.doi.org/10.20517/jtgg.2024.24
Chicago/Turabian Style
Gurusamy, Narasimman. 2024. "Commentary on “transcription regulation by long non-coding RNAs: mechanisms and disease relevance”" Journal of Translational Genetics and Genomics. 8, no.3: 281-4. http://dx.doi.org/10.20517/jtgg.2024.24
ACS Style
Gurusamy, N. Commentary on “transcription regulation by long non-coding RNAs: mechanisms and disease relevance”. J. Transl. Genet. Genom. 2024, 8, 281-4. http://dx.doi.org/10.20517/jtgg.2024.24
About This Article
Copyright
Data & Comments
Data
![](https://g.oaes.cc/oae/nuxt/img/like.08d1ca4.png)
Comments
Comments must be written in English. Spam, offensive content, impersonation, and private information will not be permitted. If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice. If you have any queries or need any help, please contact us at support@oaepublish.com.